These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 23502990)

  • 1. Effects of pitavastatin in Japanese patients with chronic heart failure: the Pitavastatin Heart Failure Study (PEARL Study).
    Takano H; Mizuma H; Kuwabara Y; Sato Y; Shindo S; Kotooka N; Fujimatsu D; Kobayashi Y; Inoue T; Node K; Komuro I;
    Circ J; 2013; 77(4):917-25. PubMed ID: 23502990
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rationale and design of a study to evaluate effects of pitavastatin on Japanese patients with chronic heart failure: the pitavastatin heart failure study (PEARL study).
    Mizuma H; Inoue T; Takano H; Shindo S; Oka T; Fujimatsu D; Kuwabara Y; Node K; Komuro I;
    Int J Cardiol; 2012 Apr; 156(2):144-7. PubMed ID: 21075465
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of intensive versus mild lipid lowering by statins in patients with ischemic congestive heart failure: Korean Pitavastatin Heart Failure (SAPHIRE) study.
    Lee HY; Cho HJ; Kim HY; Jeon HK; Shin JH; Kang SM; Baek SH
    Korean J Intern Med; 2014 Nov; 29(6):754-63. PubMed ID: 25378974
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of pitavastatin in Japanese patients with chronic heart failure. Reply.
    Takano H
    Circ J; 2013; 77(8):2205. PubMed ID: 23759658
    [No Abstract]   [Full Text] [Related]  

  • 5. Beneficial effects of pitavastatin, a 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitor, on cardiac function in ischemic and nonischemic heart failure.
    Aoyagi T; Nakamura F; Tomaru T; Toyo-Oka T
    Int Heart J; 2008 Jan; 49(1):49-58. PubMed ID: 18360064
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low-density lipoprotein cholesterol targeting with pitavastatin + ezetimibe for patients with acute coronary syndrome and dyslipidaemia: the HIJ-PROPER study, a prospective, open-label, randomized trial.
    Hagiwara N; Kawada-Watanabe E; Koyanagi R; Arashi H; Yamaguchi J; Nakao K; Tobaru T; Tanaka H; Oka T; Endoh Y; Saito K; Uchida T; Matsui K; Ogawa H
    Eur Heart J; 2017 Aug; 38(29):2264-2276. PubMed ID: 28430910
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of lipophilic statins for heart failure: a meta-analysis of 13 randomised controlled trials.
    Liu G; Zheng XX; Xu YL; Lu J; Hui RT; Huang XH
    Heart Lung Circ; 2014 Oct; 23(10):970-7. PubMed ID: 24954758
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rationale and Design of Randomized Evaluation of Aggressive or Moderate Lipid Lowering Therapy with Pitavastatin in Coronary Artery Disease (REAL-CAD) Trial.
    Miyauchi K; Kimura T; Shimokawa H; Daida H; Iimuro S; Iwata H; Ozaki Y; Sakuma I; Nakagawa Y; Hibi K; Hiro T; Fukumoto Y; Hokimoto S; Ohashi Y; Ohtsu H; Saito Y; Matsuzaki M; Nagai R;
    Int Heart J; 2018 Mar; 59(2):315-320. PubMed ID: 29503404
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of pitavastin in Japanese patients with chronic heart failure.
    D'Imperio H; Sanchis J; Núñez E; Núñez J
    Circ J; 2013; 77(8):2204. PubMed ID: 23759657
    [No Abstract]   [Full Text] [Related]  

  • 10. Effect of intensive statin therapy on regression of coronary atherosclerosis in patients with acute coronary syndrome: a multicenter randomized trial evaluated by volumetric intravascular ultrasound using pitavastatin versus atorvastatin (JAPAN-ACS [Japan assessment of pitavastatin and atorvastatin in acute coronary syndrome] study).
    Hiro T; Kimura T; Morimoto T; Miyauchi K; Nakagawa Y; Yamagishi M; Ozaki Y; Kimura K; Saito S; Yamaguchi T; Daida H; Matsuzaki M;
    J Am Coll Cardiol; 2009 Jul; 54(4):293-302. PubMed ID: 19608026
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of Ejection Fraction on Outcomes and Efficacy of Sacubitril/Valsartan (LCZ696) in Heart Failure with Reduced Ejection Fraction: The Prospective Comparison of ARNI with ACEI to Determine Impact on Global Mortality and Morbidity in Heart Failure (PARADIGM-HF) Trial.
    Solomon SD; Claggett B; Desai AS; Packer M; Zile M; Swedberg K; Rouleau JL; Shi VC; Starling RC; Kozan Ö; Dukat A; Lefkowitz MP; McMurray JJ
    Circ Heart Fail; 2016 Mar; 9(3):e002744. PubMed ID: 26915374
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of statin therapy on clinical outcomes in chronic heart failure patients according to beta-blocker use: results of CIBIS II.
    Krum H; Bailey M; Meyer W; Verkenne P; Dargie H; Lechat P; Anker S
    Cardiology; 2007; 108(1):28-34. PubMed ID: 16960445
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sacubitril/Valsartan Across the Spectrum of Ejection Fraction in Heart Failure.
    Solomon SD; Vaduganathan M; L Claggett B; Packer M; Zile M; Swedberg K; Rouleau J; A Pfeffer M; Desai A; Lund LH; Kober L; Anand I; Sweitzer N; Linssen G; Merkely B; Luis Arango J; Vinereanu D; Chen CH; Senni M; Sibulo A; Boytsov S; Shi V; Rizkala A; Lefkowitz M; McMurray JJV
    Circulation; 2020 Feb; 141(5):352-361. PubMed ID: 31736342
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of Statin Treatment on Inflammation and Cardiac Function in Heart Failure: An Adjusted Indirect Comparison Meta-Analysis of Randomized Trials.
    Bonsu KO; Reidpath DD; Kadirvelu A
    Cardiovasc Ther; 2015 Dec; 33(6):338-46. PubMed ID: 26280110
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Statin therapy in chronic heart failure: frog prince or bare frog?
    Kihara Y
    Circ J; 2013; 77(4):895-7. PubMed ID: 23502989
    [No Abstract]   [Full Text] [Related]  

  • 16. Long-term Effects of high-doSe pitavaStatin on Diabetogenicity in comparison with atorvastatin in patients with Metabolic syndrome (LESS-DM): study protocol for a randomized controlled trial.
    Park JB; Jung JH; Yoon YE; Kim HL; Lee SP; Kim HK; Kim YJ; Cho GY; Sohn DW
    Trials; 2017 Oct; 18(1):501. PubMed ID: 29078817
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of pitavastatin on cardiac structure and function and on prevention of atrial fibrillation in elderly hypertensive patients: a prospective study of 2-years' follow-up.
    Warita S; Kawasaki M; Tanaka R; Ono K; Kojima T; Hirose T; Iwama M; Watanabe T; Nishigaki K; Takemura G; Noda T; Watanabe S; Minatoguchi S
    Circ J; 2012; 76(12):2755-62. PubMed ID: 22878405
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of digoxin in patients with heart failure and mid-range (borderline) left ventricular ejection fraction.
    Abdul-Rahim AH; Shen L; Rush CJ; Jhund PS; Lees KR; McMurray JJV;
    Eur J Heart Fail; 2018 Jul; 20(7):1139-1145. PubMed ID: 29493058
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of Statins on Mortality in Heart Failure With Preserved Ejection Fraction Without Coronary Artery Disease　- Report From the JASPER Study.
    Marume K; Takashio S; Nagai T; Tsujita K; Saito Y; Yoshikawa T; Anzai T
    Circ J; 2019 Jan; 83(2):357-367. PubMed ID: 30416189
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Incidence of new-onset diabetes with 1 mg versus 4 mg pitavastatin in patients at high risk of developing diabetes during a 3-year follow-up.
    Jeong HS; Hong SJ; Son S; An H; Kook H; Joo HJ; Park JH; Yu CW; Lim DS
    Cardiovasc Diabetol; 2019 Nov; 18(1):162. PubMed ID: 31752850
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.